• Dairibord reported 26% volume growth for Q1 2026, with revenue rising 26% to US$39.40 million, supported by double-digit growth across Foods, Beverages, and Liquid Milks
• The growth was driven by recent capacity investments, including the Chipinge Steri plant commissioned in December 2025 and Q4 2025 investments in bottled Cascade and Pfuko maheu
• Export volumes declined 40% year-on-year as the group deliberately prioritised stronger domestic demand, with cost pressure from unreliable utilities, purchased water, fuel, raw materials, packaging, and longer import lead times remaining key margin risks

Harare- The dairy and beverages group's strongest quarterly volume performance in recent periods reflects deliberate capital investment made in prior quarters. The 40% export decline made to service domestic demand tells an important story about where margin is being prioritised.

Dairibord Holdings has reported 26% volume growth for the first quarter ended 31 March 2026, with revenue reaching US$39.40 million, a 26% increase compared to the same period in the prior year. The performance was driven by double-digit volume increases across all core product categories, with the Foods segment growing 31%, Beverages growing 29%, and Liquid Milks growing 15%.

The group, attributed the growth to the commissioning of the Chipinge Steri plant in December 2025 and capital investments made in Q4 2025 in bottled Cascade and Pfuko maheu.

This comes after a period in which Dairibord has been investing in production capacity expansion specifically to address demand that has been outpacing supply in key categories. The commissioning of the Chipinge Steri plant is the most significant single capacity addition, supporting the 15% increase in Liquid Milks volume by providing sterilised milk processing capacity that enables longer shelf life products to reach markets further from the production point.

The analytical foundation of Dairibord's Q1 performance is the relationship between capital investments made in prior periods and volume growth delivered in the current one. This is not a demand story in isolation, but shows a supply unlock story in which previously constrained production capacity, once expanded through deliberate capital allocation, releases volume that consumer demand was already ready to absorb.

The Chipinge Steri plant, commissioned in December 2025, supports the Liquid Milks category which accounts for 24% of the product mix. The 15% volume growth in this category reflected the plant's contribution in its first full quarter of operation.

 Liquid Milks is a category where distribution reach is constrained by shelf life, sterilised milk products with longer shelf life can penetrate geographies that fresh milk cannot reach reliably. The Chipinge plant, positioned in a different geographic location from the group's existing facilities, extends the distribution footprint in ways that raw capacity numbers do not fully capture.

The Q4 2025 investments in bottled Cascade and Pfuko maheu contributed to the 29% growth in the Beverages category, which now represents 67% of the product mix. Cascade bottled water and Pfuko maheu are both categories where packaging format and production capacity have been identified as constraints on volume, and the Q4 investment addressed those constraints directly.

The 29% Beverages growth in Q1 2026 is the return on that investment arriving one quarter after the capital was deployed.

The Foods segment's 31% growth, underpinned by strong demand particularly in the yoghurt category, reflects both improved product availability and consumer demand that the group characterises as robust. Yoghurt is a higher-value dairy segment that benefits from increasing consumer income and nutritional awareness, and the group's performance in this category suggests it is well-positioned in a segment with structural growth characteristics.

One of the most significant aspects in Dairibord's Q1 update was the 40% year-on-year decline in export volumes, which the group explicitly attributed to a strategic decision to prioritise servicing increased domestic demand. This was a deliberate margin and capacity allocation decision.

Export volumes for a Zimbabwean food manufacturer typically carry different margin characteristics than domestic sales. Export sales are denominated in foreign currency, which is attractive for working capital and balance sheet management, but they also carry higher logistics costs, longer collection cycles, and the complexity of multiple regulatory environments, including 30% surrender rules.

When domestic demand is strong and production capacity is constrained, the rational allocation is to serve the higher-margin, lower-complexity domestic market first.

The 40% export decline is therefore a consequence of the same demand strength that produced the 26% volume growth number. If the group's total production capacity had been unlimited, it would have grown both domestic and export volumes simultaneously. Since capacity is finite, the decision to prioritise domestic demand is both commercially rational and consistent with the group's strategic focus on Zimbabwe's consumer market.

The question going into Q2 and beyond is whether the ongoing capacity expansion programme, including the investments referenced for the period ahead, will reach a point where domestic demand is fully served and export capacity can be rebuilt. The group states it anticipates continued growth momentum into Q2, supported by improved product availability following recent capacity enhancements. If that improved availability reduces the domestic-versus-export trade-off, export volumes should recover as a secondary benefit of the capacity expansion programme.

Equity Axis News